1. Home
  2. NRT vs MYO Comparison

NRT vs MYO Comparison

Compare NRT & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NRT

North European Oil Royality Trust

N/A

Current Price

$9.09

Market Cap

81.0M

Sector

Energy

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.37

Market Cap

68.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRT
MYO
Founded
1975
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Industrial Specialties
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.0M
68.9M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
NRT
MYO
Price
$9.09
$1.37
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
39.9K
772.3K
Earning Date
05-29-2026
05-08-2026
Dividend Yield
10.18%
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
$21.21
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$4.99
$0.61
52 Week High
$10.49
$1.89

Technical Indicators

Market Signals
Indicator
NRT
MYO
Relative Strength Index (RSI) 60.83 49.51
Support Level $8.48 $1.36
Resistance Level $9.52 $1.89
Average True Range (ATR) 0.25 0.17
MACD 0.01 -0.04
Stochastic Oscillator 85.54 14.02

Price Performance

Historical Comparison
NRT
MYO

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: